Taipei, Taiwan

Shiow-Lin Pan

USPTO Granted Patents = 19 


 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 112(Granted Patents)


Company Filing History:


Years Active: 2005-2024

where 'Filed Patents' based on already Granted Patents

19 patents (USPTO):

Title: Innovations in Cancer Treatment: The Contributions of Shiow-Lin Pan

Introduction

Shiow-Lin Pan, based in Taipei, Taiwan, is a prolific inventor in the field of pharmaceuticals, with a remarkable portfolio encompassing 19 patents. His work centers on developing novel compounds and therapeutic approaches aimed at combating diseases, particularly cancer.

Latest Patents

Among his latest innovations are two significant patents. The first is for amino-naphthoquinone compounds and pharmaceutical compositions that target the ubiquitination-proteasome system in various diseases. This invention presents compounds characterized by low cytotoxicity that can be utilized in the treatment of disorders, notably including cancers.

The second recent patent involves anti-EGF like domain multiple 6 (EGFL6) antibodies, crucial for cancer detection and treatment. This invention includes the creation of antibodies, specifically single-chain antibody fragments (scFv) and humanized antibodies, which are designed to bind to EGFL6 effectively, inhibiting both angiogenesis and cancer cell proliferation.

Career Highlights

Shiow-Lin Pan has had a significant impact on medical science through his contributions at notable institutions, including Taipei Medical University and China Medical University. His role in these organizations has enabled him to pioneer essential research that bridges the gap between laboratory findings and practical applications in medical treatments.

Collaborations

Throughout his career, Pan has collaborated with renowned experts in the field, such as Che-Ming Teng and Sheng-Chu Kuo. These collaborations have enriched his research perspective and further fueled innovation in cancer therapies.

Conclusion

Shiow-Lin Pan continues to be a vital contributor to medical science, particularly in developing targeted treatments for cancer through his innovative patents. His dedication to research and collaboration positions him as an influential figure in the field of pharmaceuticals, significantly impacting patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…